A 72-year-old man with metastatic lung cancer and a newly diagnosed proximal deep vein thrombosis requires anticoagulation. He has normal renal functi...

Question

A 72-year-old man with metastatic lung cancer and a newly diagnosed proximal deep vein thrombosis requires anticoagulation. He has normal renal function, no history of bleeding, and is not on interacting medications. According to Canadian thrombosis guidance, what is the preferred anticoagulant strategy?

Accepted Answer

A direct oral anticoagulant at cancer-associated thrombosis dose

Answer

Warfarin with low molecular weight heparin bridging

Answer

Long-term low molecular weight heparin monotherapy

Answer

Aspirin 81 mg daily

Answer

No anticoagulation because of cancer-associated bleeding risk

ca-mccqe1 MCQ (SBA): Cancer-associated thrombosis treatment